We use cutting edge proprietary Intelligent Drug Engineering tools to solve real world drug discovery challenges through informed, logical design and decision making.
"ANYO Labs novel in silico AI-driven screening program allows for rapid and cost-efficient exploration of an extremely large portion of chemical space, which cannot be matched by any other in silico drug discovery tool."
- Prof. Johan Lennerstrand
Rapidly uncovering accurate starting points for drug engineering.
Applying our tools to enhance compounds using
Applying our tools and experience to optimize your compound through multiparameter optimization.
How we work
We're actively seeking innovative partners to collaborate on ground-breaking discovery projects.
Work with us to take new chemical entities to validation faster with a defined project scope and clear objectives.
Work with our experts to drive drug engineering.
Work under a limited project scope to accelerate development.
Experienced in working with early to late stage pharma companies
Collaborate with Anyo Labs to jointly develop novel treatments, sharing the risk and reward along the way.
Our setup for the most challenging projects.
Used to share the risks associated with drug development.
Clarity in IP ownership.
| Target/Pathway | Target | Partner | Target ID | Hit identification | Hit to lead | Lead optimization | Pre-clinical studies | Clinical trial approval |
|---|---|---|---|---|---|---|---|---|
| Oncology | Undisclosed | Yes | Hit identification | |||||
| Inflammatory | Undisclosed | No | Hit identification | |||||
| Oncology | Undisclosed | Yes | Target ID | |||||
| Oncology | Undisclosed | Yes | Lead optimization | |||||
